Enovis Corp Restructuring and Related Cost, Expected Cost
Enovis Corp (ENOV) had Restructuring and Related Cost, Expected Cost of $32.90 million as of 2017-12-31, per its 10-K filed 2018-02-16.
Discontinued › Notes › Restructuring and Related Activities
us-gaap:RestructuringAndRelatedCostExpectedCost1 · last filed 2018-02-16
- 2017-12-31: Restructuring and Related Cost, Expected Cost $32.90M.
- 2016-12-31: Restructuring and Related Cost, Expected Cost $45.00M.
- 2015-12-31: Restructuring and Related Cost, Expected Cost $70.00M.
| Period end | Restructuring and Related Cost, Expected Cost |
|---|---|
| 2017-12-31 | $32.90M 10-K · filed 2018-02-16 |
| 2016-12-31 | $45.00M 10-K · filed 2017-02-14 |
| 2015-12-31 | $70.00M 10-K · filed 2016-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |